• Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine
  • Erythropoietin
  • Idiopathic and Hereditary Pancreatitis
  • HIV1/HIV2 Antibody Screen, 3rd Generation
  • Signatera™ for Minimal Residual Disease (MRD)
  • Mycoplasma pneumoniae, Culture
  • Diltiazem, Serum
  • Lead, Blood
  • Angiosarcoma, MYC (8q24) Amplification, FISH, Tissue
  • 5-AMP-Activated Protein Kinase, Gamma-2 Subunit (PRKAG2) Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Septin 9 (SEPT9) Methylation Analysis (Epi proColon, ColoVantage)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Septin 9 (SEPT9) Methylation Analysis (Epi proColon, ColoVantage)
Medical Test

ICD10
Access to Septin 9 (SEPT9) Methylation Analysis (Epi proColon, ColoVantage) is restricted.